-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Chronic liver disease (CLD) clinically refers to a disease process of the liver, including the gradual destruction and regeneration of liver parenchyma, leading to fibrosis and cirrhosis
.
It includes a wide range of liver diseases, including inflammation (chronic hepatitis), cirrhosis and hepatocellular carcinoma
Chronic liver disease (CLD) is an important risk factor for increased morbidity and mortality in patients with acute diseases
.
For neurosurgeons, CLD and its impact on bleeding risk is an important clinical issue
Currently, few studies have investigated the relationship between CLD and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH)
.
.
In this way, Yu Zhang and others of West China Hospital of Sichuan University evaluated the relationship between CLD and mortality, and investigated whether the model of end-stage liver disease (MELD) score is an independent predictor of mortality in patients with CLD and aSAH
.
In this retrospective cohort study, they analyzed consecutive aSAH patients admitted to West China Hospital from 2009 to 2019
.
The main result is all-cause mortality in the hospital
This study included 6228 cases of aSAH, of which 489 (7.
9%) also had CLD
.
In propensity matching analysis, compared with non-CLD, CLD was associated with increased mortality in patients with aSAH (odds ratio, 2.
04 [95% CI, 1.
43-2.
92])
.
In aSAH patients with CLD, high scores in end-stage liver disease models are still associated with increased mortality
The important significance of this study lies in the discovery: in patients with aSAH, compared with non-CLD, CLD is associated with increased mortality
.
In aSAH patients with CLD, a higher end-stage liver disease model score is associated with an increase in mortality
In patients with aSAH, CLD is associated with increased mortality compared with non-CLD
Original source:
Zhang Y, Li L, Jia L, et al.
Association of Chronic Liver Disease and Mortality in Patients With Aneurysmal Subarachnoid Hemorrhage.
Stroke.
Leave a message here